Skip to main content
Erschienen in: Autoimmunity Highlights 1-2/2015

Open Access 01.08.2015 | Review Article

Automation, consolidation, and integration in autoimmune diagnostics

verfasst von: Renato Tozzoli, Federica D’Aurizio, Danilo Villalta, Nicola Bizzaro

Erschienen in: Autoimmunity Highlights | Ausgabe 1-2/2015

Einloggen, um Zugang zu erhalten

Abstract

Over the past two decades, we have witnessed an extraordinary change in autoimmune diagnostics, characterized by the progressive evolution of analytical technologies, the availability of new tests, and the explosive growth of molecular biology and proteomics. Aside from these huge improvements, organizational changes have also occurred which brought about a more modern vision of the autoimmune laboratory. The introduction of automation (for harmonization of testing, reduction of human error, reduction of handling steps, increase of productivity, decrease of turnaround time, improvement of safety), consolidation (combining different analytical technologies or strategies on one instrument or on one group of connected instruments) and integration (linking analytical instruments or group of instruments with pre- and post-analytical devices) opened a new era in immunodiagnostics. In this article, we review the most important changes that have occurred in autoimmune diagnostics and present some models related to the introduction of automation in the autoimmunology laboratory, such as automated indirect immunofluorescence and changes in the two-step strategy for detection of autoantibodies; automated monoplex immunoassays and reduction of turnaround time; and automated multiplex immunoassays for autoantibody profiling.
Literatur
1.
Zurück zum Zitat Hayter SM, Cook MC (2012) Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 11:754–765CrossRefPubMed Hayter SM, Cook MC (2012) Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 11:754–765CrossRefPubMed
2.
Zurück zum Zitat Tozzoli R, Sorrentino MC, Bizzaro N (2013) Detecting multiple autoantibodies to diagnose autoimmune comorbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist. Immunol Res 56:425–431CrossRefPubMed Tozzoli R, Sorrentino MC, Bizzaro N (2013) Detecting multiple autoantibodies to diagnose autoimmune comorbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist. Immunol Res 56:425–431CrossRefPubMed
3.
Zurück zum Zitat Damoiseaux J, Andrade LE, Fritzler MJ, Shoenfeld Y (2015) Autoantibodies 2015: From diagnostic biomarkers toward prediction, prognosis and prevention. Autoimmun Rev (epub ahead of print) Damoiseaux J, Andrade LE, Fritzler MJ, Shoenfeld Y (2015) Autoantibodies 2015: From diagnostic biomarkers toward prediction, prognosis and prevention. Autoimmun Rev (epub ahead of print)
4.
Zurück zum Zitat Bizzaro N, Tozzoli R, Villalta D (2015) Autoimmune diagnostics: the technology, the strategy and the clinical governance. Immunol Res 61:126–134CrossRefPubMed Bizzaro N, Tozzoli R, Villalta D (2015) Autoimmune diagnostics: the technology, the strategy and the clinical governance. Immunol Res 61:126–134CrossRefPubMed
5.
Zurück zum Zitat Tozzoli R, Bonaguri C, Melegari A, Antico A, Bassetti D, Bizzaro N (2013) Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med 51:129–138CrossRefPubMed Tozzoli R, Bonaguri C, Melegari A, Antico A, Bassetti D, Bizzaro N (2013) Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med 51:129–138CrossRefPubMed
6.
Zurück zum Zitat Tozzoli R, Bizzaro N (2012) The clinical autoimmunologist and laboratory autoimmunologist: the two sides of the coin. Autoimmun Rev 11:766–770CrossRefPubMed Tozzoli R, Bizzaro N (2012) The clinical autoimmunologist and laboratory autoimmunologist: the two sides of the coin. Autoimmun Rev 11:766–770CrossRefPubMed
7.
Zurück zum Zitat Nakamura RM, Bylund DJ (1994) Factors influencing changes in the clinical immunology laboratory. Clin Chem 40:2193–2204PubMed Nakamura RM, Bylund DJ (1994) Factors influencing changes in the clinical immunology laboratory. Clin Chem 40:2193–2204PubMed
8.
Zurück zum Zitat Hamilton RG (1994) The clinical immunology laboratory of the future. Clin Chem 40:2186–2192PubMed Hamilton RG (1994) The clinical immunology laboratory of the future. Clin Chem 40:2186–2192PubMed
9.
Zurück zum Zitat Normansell DE (1996) The Erwin Neter Memorial lecture: looking to the future of medical immunology laboratory, a personal view. Clin Diagn Lab Immunol 3:369–370PubMedCentralPubMed Normansell DE (1996) The Erwin Neter Memorial lecture: looking to the future of medical immunology laboratory, a personal view. Clin Diagn Lab Immunol 3:369–370PubMedCentralPubMed
10.
11.
12.
Zurück zum Zitat Wu AHB (2006) A selected history and future of immunoassay development and applications in clinical chemistry. Clin Chim Acta 369:119–124CrossRefPubMed Wu AHB (2006) A selected history and future of immunoassay development and applications in clinical chemistry. Clin Chim Acta 369:119–124CrossRefPubMed
13.
Zurück zum Zitat Fritzler MJ (2006) Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15:422–427CrossRefPubMed Fritzler MJ (2006) Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15:422–427CrossRefPubMed
14.
Zurück zum Zitat Gonzalez-Buitrago JM, Gonzalez C (2006) Present and future of the autoimmunity laboratory. Clin Chim Acta 365:50–57CrossRefPubMed Gonzalez-Buitrago JM, Gonzalez C (2006) Present and future of the autoimmunity laboratory. Clin Chim Acta 365:50–57CrossRefPubMed
15.
Zurück zum Zitat Villalta D, Tozzoli R, Tonutti E, Bizzaro N (2007) The laboratory approach to the diagnosis of autoimmune diseases: is it time to change? Autoimmun Rev 6:359–365CrossRefPubMed Villalta D, Tozzoli R, Tonutti E, Bizzaro N (2007) The laboratory approach to the diagnosis of autoimmune diseases: is it time to change? Autoimmun Rev 6:359–365CrossRefPubMed
16.
Zurück zum Zitat Tozzoli R (2007) Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun Rev 6:334–340CrossRefPubMed Tozzoli R (2007) Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun Rev 6:334–340CrossRefPubMed
17.
Zurück zum Zitat Armbruster DA, Overcash DR, Reyes J (2014) Clinical chemistry laboratory automation in the 21st century—Amat Victoria curam (victory loves careful preparation). Clin Biochem Rev 35:143–153PubMedCentralPubMed Armbruster DA, Overcash DR, Reyes J (2014) Clinical chemistry laboratory automation in the 21st century—Amat Victoria curam (victory loves careful preparation). Clin Biochem Rev 35:143–153PubMedCentralPubMed
18.
Zurück zum Zitat Hoffmann GE (1998) Concepts for the third generation of laboratory systems. Clin Chim Acta 278:203–216CrossRefPubMed Hoffmann GE (1998) Concepts for the third generation of laboratory systems. Clin Chim Acta 278:203–216CrossRefPubMed
19.
20.
Zurück zum Zitat Plebani M (2013) Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 51:741–745PubMed Plebani M (2013) Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 51:741–745PubMed
21.
Zurück zum Zitat Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F et al (2002) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117:316–324CrossRefPubMed Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F et al (2002) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117:316–324CrossRefPubMed
22.
Zurück zum Zitat Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M et al (2014) International recommendations for the assessment of autoantibodies to celluar antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 73:17–23CrossRefPubMed Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M et al (2014) International recommendations for the assessment of autoantibodies to celluar antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 73:17–23CrossRefPubMed
23.
Zurück zum Zitat Csernok E, Jolle JU (2010) Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA—evidence-based immunology? Autoimmun Highlights 1:39–43CrossRef Csernok E, Jolle JU (2010) Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA—evidence-based immunology? Autoimmun Highlights 1:39–43CrossRef
24.
Zurück zum Zitat Tozzoli R, Antico A, Porcelli B, Bassetti D (2012) Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Autoimmun Highlights 3:59–65CrossRef Tozzoli R, Antico A, Porcelli B, Bassetti D (2012) Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Autoimmun Highlights 3:59–65CrossRef
25.
Zurück zum Zitat Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F et al (2013) Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev 13:292–298CrossRefPubMed Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F et al (2013) Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev 13:292–298CrossRefPubMed
26.
Zurück zum Zitat Buzzulini F, Rigon A, Soda P, Onofri L, Infantino M, Arcarese L et al (2014) The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system. Arthritis Res Ther 16:R71PubMedCentralCrossRefPubMed Buzzulini F, Rigon A, Soda P, Onofri L, Infantino M, Arcarese L et al (2014) The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system. Arthritis Res Ther 16:R71PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Sowa M, Grossmann K, Knutter I, Hiemann R, Rober N, Anderer U et al (2014) Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA. PLoS One 9:e107743PubMedCentralCrossRefPubMed Sowa M, Grossmann K, Knutter I, Hiemann R, Rober N, Anderer U et al (2014) Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA. PLoS One 9:e107743PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Bertin D, Jourde-Chiche N, Bongrand P, Bardin N (2013) Original approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescence. Clin Dev Immunol 2013:182172PubMedCentralCrossRefPubMed Bertin D, Jourde-Chiche N, Bongrand P, Bardin N (2013) Original approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescence. Clin Dev Immunol 2013:182172PubMedCentralCrossRefPubMed
29.
Zurück zum Zitat Peng X, Tang J, Wu Y, Yang B, Hu J (2014) Novel method for ANA quantitation using IIF imaging system. J Immunol Methods 404:52–58CrossRefPubMed Peng X, Tang J, Wu Y, Yang B, Hu J (2014) Novel method for ANA quantitation using IIF imaging system. J Immunol Methods 404:52–58CrossRefPubMed
30.
Zurück zum Zitat Maenhout TM, Bonroy C, Verfaillie C, Stove V, Devreese K (2014) Automated indirect immunofluorescence microscopy enables the implementation of a quantitative internal quality control system for anti-nuclear antibody (ANA) analysis. Clin Chem Lab Med 52:989–998CrossRefPubMed Maenhout TM, Bonroy C, Verfaillie C, Stove V, Devreese K (2014) Automated indirect immunofluorescence microscopy enables the implementation of a quantitative internal quality control system for anti-nuclear antibody (ANA) analysis. Clin Chem Lab Med 52:989–998CrossRefPubMed
31.
Zurück zum Zitat Pantanowitz L, Dickinson K, Evans AJ, Hassell LA, Hendricks WH, Lennerz JK et al (2014) American Telemedicine Association clinical guidelines for telepathology. J Pathol Inform 5:39PubMedCentralCrossRefPubMed Pantanowitz L, Dickinson K, Evans AJ, Hassell LA, Hendricks WH, Lennerz JK et al (2014) American Telemedicine Association clinical guidelines for telepathology. J Pathol Inform 5:39PubMedCentralCrossRefPubMed
32.
33.
Zurück zum Zitat Wiik AS, Bizzaro N (2010) Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases. It is all about the patient! Autoimmun Highlights 3:35–49CrossRef Wiik AS, Bizzaro N (2010) Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases. It is all about the patient! Autoimmun Highlights 3:35–49CrossRef
34.
Zurück zum Zitat Damoiseaux JGMC, Cohen Terwaert JW (2006) Fron ANA to ENA: how to proceed? Autoimmun Rev 5:10–17CrossRefPubMed Damoiseaux JGMC, Cohen Terwaert JW (2006) Fron ANA to ENA: how to proceed? Autoimmun Rev 5:10–17CrossRefPubMed
35.
Zurück zum Zitat Verboeket-van WPHG, de Venne KM, Aakre Watine J, Oosterhuis WP (2012) Reflective testing: adding value to laboratory testing. Clin Chem Lab Med 50:1249–1252 Verboeket-van WPHG, de Venne KM, Aakre Watine J, Oosterhuis WP (2012) Reflective testing: adding value to laboratory testing. Clin Chem Lab Med 50:1249–1252
36.
Zurück zum Zitat De Joode AAE, Roozendal C, van der Leij MJ, Bungener LB, Sanders JSF, Stegeman CA (2014) Performance of two strategy for urgent ANCA and anti-GBM analysis in vasculitis. Eur J Intern Med 25:182–186CrossRefPubMed De Joode AAE, Roozendal C, van der Leij MJ, Bungener LB, Sanders JSF, Stegeman CA (2014) Performance of two strategy for urgent ANCA and anti-GBM analysis in vasculitis. Eur J Intern Med 25:182–186CrossRefPubMed
37.
Zurück zum Zitat Vaidya B, Pearce SHS (2014) Diagnosis and management of thyrotoxicosis. J Brit Med 349:g5128CrossRef Vaidya B, Pearce SHS (2014) Diagnosis and management of thyrotoxicosis. J Brit Med 349:g5128CrossRef
38.
Zurück zum Zitat Lynch MJ, Woodford NWF (2014) Sudden unexpected death in the setting of undiagnosed Graves’ disease. Forensic Sci Med Pathol 10:452–456CrossRefPubMed Lynch MJ, Woodford NWF (2014) Sudden unexpected death in the setting of undiagnosed Graves’ disease. Forensic Sci Med Pathol 10:452–456CrossRefPubMed
39.
Zurück zum Zitat Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya J-M (2013) Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev 12:380–395CrossRefPubMed Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya J-M (2013) Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev 12:380–395CrossRefPubMed
40.
Zurück zum Zitat Rangel ML, Alghamdi I, Contreras G, Harrington T, Thomas DB, Barisoni L et al (2013) Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. Lupus 22:854–864CrossRef Rangel ML, Alghamdi I, Contreras G, Harrington T, Thomas DB, Barisoni L et al (2013) Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. Lupus 22:854–864CrossRef
41.
Zurück zum Zitat Kostantinov KN, Tzamaloukas A, Rubin RL (2013) Detection of autoantibodies in a point-of-care rheumatology setting. Autoimmun Highlights 4:55–61CrossRef Kostantinov KN, Tzamaloukas A, Rubin RL (2013) Detection of autoantibodies in a point-of-care rheumatology setting. Autoimmun Highlights 4:55–61CrossRef
42.
Zurück zum Zitat Tozzoli R, Villalta D (2014) Autoantibody profiling of patients with antiphospholipid syndrome using an automated multiplexed immunoassay system. Autoimmun Rev 13:59–63CrossRefPubMed Tozzoli R, Villalta D (2014) Autoantibody profiling of patients with antiphospholipid syndrome using an automated multiplexed immunoassay system. Autoimmun Rev 13:59–63CrossRefPubMed
43.
Zurück zum Zitat Holding S, Wilson F, Spradbery D (2014) Clinical evaluation of the Bioplex 2200 celiac IgA and IgG kits—A novel multiplex screen incorporating an integral check for IgA deficiency. J Immunol Methods 405:29–34CrossRefPubMed Holding S, Wilson F, Spradbery D (2014) Clinical evaluation of the Bioplex 2200 celiac IgA and IgG kits—A novel multiplex screen incorporating an integral check for IgA deficiency. J Immunol Methods 405:29–34CrossRefPubMed
44.
Zurück zum Zitat Martin L, Steber WA, Lupton TL, Mahler M, Fitch CM, McMillan JD, et al (2015) Clinical and serological analysis of patients with positive anticyclic citrullinated peptide antibodies referred through a rheumatology central triage system. J Rheumatol (Epub ahead of print) PMID: 25641884 Martin L, Steber WA, Lupton TL, Mahler M, Fitch CM, McMillan JD, et al (2015) Clinical and serological analysis of patients with positive anticyclic citrullinated peptide antibodies referred through a rheumatology central triage system. J Rheumatol (Epub ahead of print) PMID: 25641884
Metadaten
Titel
Automation, consolidation, and integration in autoimmune diagnostics
verfasst von
Renato Tozzoli
Federica D’Aurizio
Danilo Villalta
Nicola Bizzaro
Publikationsdatum
01.08.2015
Verlag
Springer International Publishing
Erschienen in
Autoimmunity Highlights / Ausgabe 1-2/2015
Print ISSN: 2038-0305
Elektronische ISSN: 2038-3274
DOI
https://doi.org/10.1007/s13317-015-0067-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.